AbbVie Biotech Ventures logo

AbbVie Biotech Ventures

North America, Illinois, United States, North Chicago

Description

AbbVie Biotech Ventures, an Illinois-based company, makes investments in emerging biotech and pharmaceutical companies.

Investor Profile

AbbVie Biotech Ventures has made 53 investments, with 2 in the past 12 months and 17% as lead.

Stage Focus

  • Series A (43%)
  • Series B (23%)
  • Series C (13%)
  • Seed (8%)
  • Series Unknown (6%)
  • Series D (4%)
  • Series E (4%)

Country Focus

  • United States (87%)
  • United Kingdom (4%)
  • Germany (2%)
  • Italy (2%)
  • The Netherlands (2%)
  • China (2%)
  • Australia (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Life Science
  • Medical Device
  • Biopharma
  • Genetics
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does AbbVie Biotech Ventures frequently co-invest with?

Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 9
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 5
SV Health Investors
North America, Massachusetts, United States, Boston
Co-Investments: 5
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 11
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 6
Mission Bay Capital
North America, California, United States, San Francisco
Co-Investments: 5
MRL Ventures Fund
North America, Massachusetts, United States, Cambridge
Co-Investments: 7
Dementia Discovery Fund
Europe, England, United Kingdom, London
Co-Investments: 7
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 8
The Column Group
North America, California, United States, San Francisco
Co-Investments: 5

Which angels does AbbVie Biotech Ventures often collaborate with?

PG
North America, Illinois, United States, Chicago
Shared Deals: 1
David R. Walt
North America, Massachusetts, United States, Boston
Shared Deals: 1
SK
North America, New York, United States, New York
Shared Deals: 1
BG
North America, Washington, United States, Seattle
Shared Deals: 1
JR
North America, California, United States, San Francisco
Shared Deals: 1
TA
North America, Massachusetts, United States, Cambridge
Shared Deals: 1
JY
North America, California, United States, San Francisco
Shared Deals: 1
Shared Deals: 1
MT
North America, New York, United States, New York
Shared Deals: 1
EL
North America, Illinois, United States, Chicago
Shared Deals: 1

What are some of recent deals done by AbbVie Biotech Ventures?

Oisin Biotechnologies

Seattle, Washington, United States

Oisin Biotechnologies is a drug development company focused on mitigating the senolytic technology to combat age-related diseases.

BiopharmaBiotechnologyMedical
Series AJul 24, 2024
Amount Raised: $15,000,000
Third Arc Bio

Boston, Massachusetts, United States

Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases.

BiotechnologyHealth CareLife ScienceMedicalOncology
Series AJul 23, 2024
Amount Raised: $165,000,000
Accent Therapeutics

Lexington, Massachusetts, United States

Accent Therapeutics is a biopharmaceutical company.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series CJan 23, 2024
Amount Raised: $75,000,000
DISCO Pharmaceuticals

Cologne, Nordrhein-Westfalen, Germany

DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.

ManufacturingPharmaceuticalTherapeutics
SeedJan 16, 2024
Amount Raised: $21,757,127
Mozart Therapeutics

Seattle, Washington, United States

Mozart is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases.

Biotechnology
Series AJun 7, 2023
Amount Raised: $25,000,000
Quanta Therapeutics

San Francisco, California, United States

Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series DMay 22, 2023
Amount Raised: $50,700,000
Jnana Therapeutics

Boston, Massachusetts, United States

Jnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.

BiotechnologyHealth CareMedicalTherapeutics
Series CNov 15, 2022
Amount Raised: $107,000,000
AmbAgon Therapeutics

San Francisco, California, United States

AmbAgon Therapeutics is a developer of cancer molecule therapeutics.

BiotechnologyMedicalProduct Research
Series AJan 6, 2022
Amount Raised: $85,000,000
Nitrase Therapeutics

Jackson, Mississippi, United States

Nitrase Therapeutics is developing drugs against newly discovered nitration enzyme(s).

BiotechnologyHealth CareTherapeutics
Series ANov 2, 2021
Amount Raised: $7,000,000
Quanta Therapeutics

San Francisco, California, United States

Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series COct 26, 2021
Amount Raised: $60,000,000